Reuters logo
6 months ago
BRIEF-Impax confirms patent challenge relating to generic Aubagio
January 6, 2017 / 1:48 PM / 6 months ago

BRIEF-Impax confirms patent challenge relating to generic Aubagio

1 Min Read

Jan 6 (Reuters) - Impax Laboratories Inc :

* Impax confirms patent challenge relating to generic Aubagio (teriflunomide) tablets, 14 mg

* Impax Laboratories Inc - filed ANDA with FDA containing a paragraph IV certification for a generic version of Aubagio tablets 14 mg

* Impax Laboratories says plaintiffs, Sanofi-Aventis U.S. Llc, Aventisub Llc, Sanofi, Genzyme Corp filed suit for patent infringement against co Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below